TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Fear Not: Friends Is Staying on Netflix (and These Shows Are Coming)
JIM CRAMER

Netflix, Cytokinetics, Yeti Holdings: 'Mad Money' Lightning Round

PRESS RELEASES

Cytokinetics Announces Recipients of Third Annual Communications Fellowship Grants

PRESS RELEASES

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRESS RELEASES

Cytokinetics Announces First Patient Dosed In Cohort 2 Of Redwood-HCM

PRESS RELEASES

Cytokinetics Granted Orphan Drug Designation For CK-3773274 For The Treatment Of Hypertrophic Cardiomyopathy

PRESS RELEASES

Cytokinetics To Present At The H.C. Wainwright BioConnect 2021 Virtual Conference

PRESS RELEASES

Cytokinetics Regains European Rights To Omecamtiv Mecarbil

PRESS RELEASES

Cytokinetics Announces Three Presentations At The International Symposium On ALS/MND

PRESS RELEASES

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

PRESS RELEASES

Cytokinetics To Participate In Upcoming Investor Conferences

PRESS RELEASES

Cytokinetics Names Nancy Wysenski To Board Of Directors

PRESS RELEASES

Cytokinetics Announces Presentations Related To Health Economics And Outcomes Research In Heart Failure And Hypertrophic Cardiomyopathy At The AHA Scientific Sessions 2020

PRESS RELEASES

Cytokinetics Announces Preclinical Data For CK-3773274 And CK-3772271 Presented At The AHA Scientific Sessions 2020

PRESS RELEASES

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRESS RELEASES

Cytokinetics Announces Six Presentations Related To Heart Failure And Hypertrophic Cardiomyopathy At The AHA Scientific Sessions 2020

PRESS RELEASES

Cytokinetics To Announce Third Quarter Results On November 4, 2020

PRESS RELEASES

Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

PRESS RELEASES

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRESS RELEASES

Cytokinetics Announces Data From Two Presentations At The HFSA Virtual Annual Scientific Meeting 2020

PRESS RELEASES

Cytokinetics Announces Data To Be Presented At the HFSA Virtual Annual Scientific Meeting 2020

PRESS RELEASES

Cytokinetics Announces Third Annual Communications Fellowship Program Call For Proposals

PRESS RELEASES

Cytokinetics Announces Initiation Of Phase 1 Clinical Study Of CK-3772271

PRESS RELEASES

Cytokinetics Announces GALACTIC-HF Accepted For Presentation In Late Breaking Clinical Trial Session At American Heart Association Scientific Sessions

PRESS RELEASES

Cytokinetics To Participate In Upcoming Investor Conferences

PRESS RELEASES

Cytokinetics And Cure SMA Renew Partnership To Advance Education And Awareness Of SMA